Back to Search Start Over

Photosensitizing drug reactions

Authors :
Simone Montgomery
Scott Worswick
Source :
Clinics in Dermatology. 40:57-63
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

Photosensitizing drug reactions are cutaneous eruptions that occur after exposure to ultraviolet radiation in patients using photosensitizing medications. The reactions can be broadly classified into phototoxic and photoallergic, with the former being much more common and well documented. There is an extensive list of photosensitizing medications, especially in the case of phototoxicity. The most common are amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, vemurafenib, and voriconazole. Most of the medications implicated in photosensitivity share an action spectrum within the ultraviolet A range. Distinguishing between phototoxicity and photoallergy can be difficult, because some clinical overlap exists between the two disorders. It is often done based on pathogenesis, clinical presentation, and diagnosis. Management is similar for both types of reactions, with the gold standard being prevention. This review provides an overview of the photosensitizing drug reactions and highlights the similarities and differences between phototoxicity and photoallergy, as well as other photosensitizing drug reactions in the phototoxicity family including lichenoid reactions and pseudoporphyria.

Details

ISSN :
0738081X
Volume :
40
Database :
OpenAIRE
Journal :
Clinics in Dermatology
Accession number :
edsair.doi.dedup.....269680be649e5b574459292a7485dacb
Full Text :
https://doi.org/10.1016/j.clindermatol.2021.08.014